title: [Management of pregnancy in patients with systemic lupus erythematosus].
abstract: Patients with systemic lupus erythematosus are exposed to a remarkably high number of maternal-fetal complications during pregnancy. Knowledge regarding the reciprocal influence between lupus and pregnancy is the starting point to assure that these patients are correctly monitored. It is also important to carry out comprehensive preconception evaluation to individually evaluate the risk of each patient. The immunological profile, history of nephritis, presence of chronic damage and disease activity are the basic data that will determine the specific individual risk profile. Finally, correct drug management must be assured during this period, based on the safety profile of the different treatments during pregnancy and lactation.
authors.affiliation: Unidad de Investigación de Enfermedades Autoinmunes, Servicio de Medicina Interna, Hospital de Cruces, Barakaldo, Bizkaia, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Ugarte
authors.forename: I
authors.initials: I
authors.lastname: Villar
authors.forename: G
authors.initials: G
authors.lastname: Ruiz-Irastorza
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001942:Breast Feeding; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D011181:Postnatal Care / Q000379:methods*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D011295:Prenatal Care / Q000379:methods*
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents